The Patent Finder

Terms ending in 2030

Acceleron Pharma Inc.

Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,138,142Methods for Increasing Adiponectin in a Patient in Need Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 8,945,877Polynucleotides Encoding BMP-ALK3 Antagonists
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 8,178,488Methods for Increasing Thermogenic Adipocytes
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 8,293,881An Isolated Nucleic Acid Encoding a Truncated Actriib Fusion Protein
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 8,703,694Methods for Increasing Thermogenic Adipocytes
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,745,559A Method for Decreasing the Body Fat Content in a Subject by Administering an Actriib Protein
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,790,284Methods for Increasing Thermogenic Adipocytes
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 10,358,633Method for Decreasing the Body Fat Content in a Subject by Administering an Actriib Protein
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 10,968,282Methods for Screening Compounds for Increasing Thermogenic Adipocytes
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 11,066,654Methods and Compositions for Reducing Serum Lipids
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
3 more term ends in 2030 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited